CB2 Receptor Agonist Effective for Neuropathic Pain in Preclinical Studies
CNTX-6016, a highly-selective cannabinoid receptor type 2 agonist, was found to provide adequate analgesia in preclinical models of neuropathic pain.
Neuropathic Pain
Benefit of Prompt Corticosteroid Use in Immune Checkpoint Inhibitor-Related Neuropathy
Recognition of the wide phenotype spectrum in immune checkpoint inhibitor-related neuropathy and prompt management with corticosteroids may lead to favorable outcomes.
Neuropathic Pain May Not Predict Chronic Widespread Pain in Patients With Regional Pain
The risk for developing chronic widespread pain was found to be comparable in patients with regional pain with or without neuropathic pain.
Perineural Injection of Platelet-Rich Plasma for Peripheral Neuropathy Pain
Perineural injection of platelet-rich plasma may improve pain and numbness associated with diabetic peripheral neuropathy, and enhance peripheral nerve function.
High Prevalence of Neuropathic-Like Pain in Psoriatic Arthritis
The prevalence of neuropathic-like pain was found to be high in patients with psoriatic arthritis, a condition that may be associated with higher disease activity and fibromyalgia.
Neuropathic Pain May Increase Risk for Low Physical, Mental Quality of Life
The presence of neuropathic pain was identified as a risk factor for low physical and mental quality of life in middle-aged and elderly patients.
Diabetic Peripheral Neuropathy Associated With Increased Health Care Costs
Researchers found a substantial cohort of adults with diabetic peripheral neuropathy in the United States with high financial and social costs.
Sensory Sensitivities in Failed Back Surgery Syndrome vs Low Back-Related Leg Pain
Detection sensitivity may be altered on the symptomatic side in patients with low back pain with a dominant neuropathic pain component compared with patients with LBP with a primary nociceptive component.
Reviewing Off-Label Uses of Gabapentinoids
As part of current efforts to reduce unnecessary opioid consumption, clinicians have increasingly prescribed gabapentinoids for a range of pain disorders.
Addition of Gabapentin to Valacyclovir to Treat Herpes Zoster Rash Does Not Improve Pain
The addition of gabapentin to valacyclovir within 72 hours of onset of a herpes zoster rash was not found to provide further relief from acute herpetic pain or to better prevent postherpetic neuralgia.
Next post in Neuropathic Pain
